Related Experiment Video
Updated: May 25, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
The kidney and hypertension: novel insights from transgenic models
Marcela Herrera1, Thomas M Coffman
1Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Purpose Of Review:
Despite decades of study, the pathogenesis of essential hypertension remains obscure, but the kidney appears to play a central role. Technology for manipulation of the mouse genome has been immensely valuable in dissecting pathways involved in blood pressure control. This review summarizes recent studies employing this technology to understand signaling pathways and specific cell lineages within the kidney that are involved in the regulation of sodium excretion impacting blood pressure homeostasis.
Recent Findings:
We review a series of recent studies of regulatory pathways affecting sodium excretion by the kidney including the renin-angiotensin system, the mineralocorticoid receptor, the endothelin system, nitric oxide, and the with-no-lysine (K)/sterile 20-like kinase pathway. We have specifically highlighted studies utilizing transgenic mouse models, which provide a powerful mechanism for defining the role of proteins and pathways on sodium balance and blood pressure in the intact organism.
Summary:
These studies underscore the importance of the kidney in regulation of blood pressure and the pathogenesis of hypertension. Transgenic mouse models provide a powerful approach to identifying key cell lineages and molecular pathways causing hypertension. These pathways represent potential targets for novel antihypertensive therapies.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hormonal Regulation
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

